News|Articles|April 27, 2015

Endpoints in Cancer Trials: Putting Patients First

In the debate over patient-centric considerations in cancer care, one main focus has been the choice of proper endpoints for clinical trials.

In the debate over patient-centric considerations in cancer care, one main focus has been the choice of proper endpoints for clinical trials. As the CEO of a cancer therapeutics company with multiple ongoing trials in a wide range of cancers, as well as a cancer survivor myself, I have found myself drawn into this discussion and have developed a core argument as well as some complementary insights. Before I share these, let me offer a bit of context.

Internal server error